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Case presentation
A 62-year-old male with a 22-year history of albuminuria and pro-
gressive renal insufficiency was admitted to the hospital for placement
of a vascular access preparatory to dialysis. The left kidney had been
found to be hypoplastic when proteinuria was first noted. The causes of
his renal failure were presumed to be chronic glomerulonephritis and
hypertension. The patient complained of nocturnal pruritis at the time
of admission but no other symptoms.
The medical history was otherwise unremarkable except for several
episodes of acute gout. Medications being taken prior to admission
included minoxidil, furosemide, metoprolol, allopurinol, calcitriol, alu-
minum hydroxide, and calcium carbonate.
Physical examination revealed a blood pressure of 96/60 mm Hg;
pulse, 98 beats/mm; respiratory rate, 20/mm; and oral temperature,
94°F. The sclerae were pale and anicteric, and the pupils were equally
reactive. The fundi revealed arteriovenous nicking but no hemorrhages
or exudates. The chest was clear, cardiac examination revealed an S4
gallop but no murmurs or rubs. The jugular venous pressure was normal
and peripheral edema was not present. The abdomen revealed no
organomegaly, tenderness, or masses. Guaiac test of the stool was
negative, and the neurologic examination was unremarkable. Several
excoriated areas were present on the arms and back.
Laboratory studies showed a hematocrit of 30.5%; white blood cell
count, 8900 mm3 with a normal differential; platelet count, 177,000
mm3; BUN, 108 mg/dl; creatinine, 6.8 mg/dl; sodium, 141 mEq/liter;
potassium, 3.0 mEq/liter; chloride, 106 mEq/liter; carbon dioxide, 24
mEg/liter; anion gap, 11 mEg/liter; calcium, 11.0 mg/dl; phosphate, 4,8
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mg/dl; and glucose, 145 mg/dl. Urinalysis revealed a specific gravity of
1.010; pH 6.0; trace protein; occasional white blood cells; and no red
blood cells, casts, or crystals. A 12-hour urine collection disclosed 638
mg of creatinine and a creatinine clearance of 13 mI/mm.
The patient had dialysis twice via a subclavian catheter, and an
arteriovenous fistula was constructed. All antihypertensive medications
were discontinued and the patient was discharged on a regimen of
furosemide, aluminum hydroxide, and allopurinol.
Despite discontinuation of calcitriol and calcium carbonate, the
patient's serum calcium remained above 10 mg/dl. The serum PTH level
was 4200 dEq/ml when the serum calcium was 10.3 mg/dl. Some
suppression of the serum PTH level was obtained (to 2400 pJEq/ml)
when the serum calcium was raised to 11 mg/dl, but this decrease was
followed by rebound of the PTH to the previous level. Subperiosteal
resorption was not seen on radiographs of the hands, but a sonogram of
the neck revealed 2 large (2 x 1.5 cm), solid, cystic parathyroid masses.
A subtotal parathyroidectomy (3.5 glands) therefore was performed. At
the time of surgery, arterial blood gas measurements revealed a pH of
7.38, PaCO2 of 35 mm Hg, and a plasma bicarbonate of 20.4 mEq/liter.
Since surgery, the serum calcium level has remained below 10 mg/dl,
and renal function has stabilized with a creatinine clearance of 18
mI/mm. The total co2 stabilized at 22 mEq/liter while the patient was
taking furosemide, aluminum hydroxide, and allopurinol. Repeated
measurement of the PTH level was 800 lEq/ml. The most recent
evaluation revealed a creatinine clearance of 14 ml/min; sodium, 144
mEg/liter; potassium, 5.2 mEg/liter; chloride, 107 mEg/liter; carbon
dioxide, 22 mEg/liter; anion gap, 15 mEg/liter; calcium, 9.0 mg/dl;
phosphate, 4.6 mg/dl; BUN, 74 mg/dl; and creatinine, 5.9 mg/dl.
Discussion
Da. DAVtD G. WARNOCK (Chief, Nephrology Section, San
Francisco Veterans Administration Medical Center, and Pro-
fessor of Medicine and Pharmacology, University of Califor-
nia, San Francisco, California): The patient presented today
has clearly established chronic renal insufficiency and surgically
proved diffuse hyperparathyroidism. Although the exact cause
of renal insufficiency has not been documented, it is notable
that his course has stabilized since he had a subtotal parathy-
roidectomy 1.5 years ago. At the time of surgery, determina-
tions of arterial blood gases documented a mild metabolic
acidosis with appropriate respiratory adaptation, despite ad-
vanced renal insufficiency with a creatinine clearance of 13
ml/min. For the purposes of our discussion of uremic acidosis,
the questions we need to address include: (1) What is uremic
acidosis? (2) What are the pathophysiologic processes that
cause acidosis to develop in the setting of chronic renal insuf-
ficiency? (3) What are the renal and extrarenal adaptations to
chronic renal insufficiency that defend acid-base homeostasis?
The case presentation is instructive, particularly if we ask why
acidosis was so mild in this patient.
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Clinical features of uremnic acidosis
Chronic progressive renal disease usually results in some
degree of systemic acidosis when the glomerular filtration rate
is reduced to 25 mllmin or less [1]. Metabolic acid production
generally is not increased in patients with chronic renal insuf-
ficiency [2]; therefore the development of acidosis reflects an
impairment in the renal acidification mechanisms [3] as well as
some limitations in the renal homeostatic responses to acidosis.
Reduced bicarbonate reabsorption [4] and impaired ammonia
production [5] are thought to be the underlying disturbances in
the renal acidification process characteristic of uremic acidosis.
Hyperchloremic metabolic acidosis can develop early in the
course of renal disease but the acidosis "converts" to an
anion-gap form when the glomerular filtration rate falls below 20
mLfmin [6]. Hyperchloremic metabolic acidosis, well described
in patients with tubulointerstitial disease [3, 6], also has been
seen in patients with primary glomerular disease [7]. One of the
classic studies analyzing metabolic acidosis in patients with
chronic renal insufficiency was done here at the New England
Medical Center. In a retrospective analysis of 138 ambulatory
patients with stable renal function, Widmer, Gerhardt, Har-
rington, and Cohen examined the relationships between serum
electrolytes and renal function, as assessed by serum creatinine
measurements [7]. The study excluded patients with vomiting,
diarrhea, or volume depletion and those who had received
diuretics, alkali, steroids, potassium-exchange resins, or antac-
ids. Patients also were excluded who had multiple myeloma, or
who had undergone adrenalectomy or parathyroidectomy. Ob-
viously these patients were highly selected; many of the pa-
tients in a typical renal clinic would not meet these criteria, but
the goal of the investigators was to determine the relationship
between the various serum electrolytes and renal function in the
steady state. The final analysis included 41 patients who were
16 to 73 years old. There were 25 men and 16 women; 18 had
glomerular disease, 16 had tubulointerstitial disease, and 7
patients had renal insufficiency of unknown cause. An anion-
gap acidosis was found in patients whose glomerular filtration
rate fell below 20 mI/mm and whose serum creatinine concen-
trations were greater than 4 mg/dl. Somewhat surprisingly,
when the serum creatinine was less elevated (that is, in the
range of 2 to 4 mg/dl), there was a slight increase in the serum
chloride level (c=5 mEq/liter) and a parallel decrease (of =6
mEq/liter) in the serum bicarbonate concentration; that is, a
mild hyperchloremic metabolic acidosis was present. These
mild changes in serum electrolytes were found in patients with
all forms of chronic renal disease and were not markers for
tubulointerstitial disease. In addition, relative hyperkalemia
was uniformly noted in the patients with moderate renal insuf-
ficiency [7]. Hyporeninemic hypoaldosteronism has been well
described in patients with moderate renal insufficiency [8], and
one might be tempted to implicate it in the pathogenesis of the
associated mild metabolic acidosis. Yet the development of
hyperchloremic metabolic acidosis in the patients with moder-
ate renal insufficiency (serum creatinine levels between 2 and 4
mg/dl) appears to have been too uniform to be explained by
aldosterone insufficiency [91. The development of an anion-gap
metabolic acidosis in advanced renal insufficiency indicates that
the surviving nephrons are not able to match the daily excretion
of "acid anions" (mostly sulfate, phosphate, and various or-
ganic-acid anions that have not been completely oxidized) with
their daily production, just as they are not able to excrete the
daily endogenous acid load [2]; the retention of these acid
anions and hydrogen ions generates the so-called anion-gap
metabolic acidosis characteristic of uremia [10].
Patho genesis of uremic acidosis
If serum bicarbonate levels in uremic patients are raised
towards normal, the urine pH rises and the already reduced
renal net acid excretion falls further. At times, overt
bicarbonaturia occurs [4]. In the absence of bicarbonate sup-
plementation, however, the urine pH usually is less than 5.4.
This finding suggests that the ability of the distal nephron to
acidify the urine (that is, maintain a normal pH gradient) is
intact in chronic renal failure. Furthermore, the capacity of the
distal nephron's proton secretory systems to respond to an
increase in buffer delivery (such as that following administra-
tion of a phosphate load) is also well maintained (reviewed in
Ref. 11). There is an important distinction, however, between
simple acidification of the urine and renal net acid excretion
(defined as the sum of ammonium excretion and titratable acid
minus the excretion of bicarbonate). Unlike patients with distal
renal tubular acidosis, in whom the primary acidification defect
resides in the distal proton secretory mechanisms, patients with
chronic renal insufficiency appear to have impaired renal net
acid excretion because of inadequate or inappropriate delivery
of buffer to the distal nephron acidification sites. I will now
address the defects in the renal excretion of ammonium and
reabsorption of bicarbonate, which are the central factors
responsible for the development of acidosis in chronic renal
insufficiency.
Ammonium excretion. A major factor in the limitation of
renal net acid excretion in chronic renal insufficiency is inade-
quate renal ammonium excretion. Although there is an adaptive
increase in renal ammonia production by the remaining neph-
rons, this adaptation is not sufficient to meet the requirement
for excretion of daily metabolic acid production; thus, despite
adaptation, an absolute decrease in overall renal ammonia
production eventually ensues [1]. Because renal ammonia pro-
duction can normally increase four- or fivefold, this limitation
only becomes evident when the glomerular filtration rate falls
below approximately 20% of normal. In the normal rat, most of
the ammonia produced by the nephron enters the tubular fluid
in the early proximal tubule (Fig. 1; open bars), but approxi-
mately one-third of that secreted in the early segments is
absorbed in the late proximal tubule [12]. In chronic metabolic
acidosis (induced by the administration of NH4C1), the ammo-
nia secretory process is stimulated, ammonia entry into the
early proximal tubule increases, and ammonia is secreted
(rather than absorbed) in the late proximal tubule (Fig. 1;
hatched bars). Buerkert and colleagues examined the ammo-
nium excretory response in an animal model of chronic renal
insufficiency, the five-sixths renal ablation model [13]. As Table
1 shows, in this model of chronic renal insufficiency the
glomerular filtration rate is reduced more than 50%, and meta-
bolic acidosis develops with a systemic pH of approximately
7.30. Just as in humans with chronic renal insufficiency, the
urine pH in these rats is acidic during the systemic acidosis.
Despite the excretion of an acid urine, systemic acidosis
developed in the rats with the remnant kidney in association
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Fig. 1. Ammonia transport along the proximal tubule. Net rates of
ammonia secretion (negative values) or absorption are shown at early
and late proximal tubule sites. These data were obtained in micropunc-
ture experiments in normal rats (open bars), and in rats made chroni-
cally acidotic with administration of ammonium chloride; * = P < 0.01.
(Reproduced by permission of the Journal of Clinical Investigation
[12].)
with a reduction in renal net acid excretion from 1.22 to 0.80
nEq/min. The acid urine results from the relative lack of
available buffer in the urine. Note that renal ammonium excre-
tion fell from 0.87 to 0.50 nEq/min; this reduction in ammonium
excretion can fully account for the fall in net acid excretion [131.
Another facet of the abnormalities in renal ammonia produc-
tion in chronic renal insufficiency was studied by Tizinello and
coworkers [14]. They found that ammonia production was
increased fourfold in humans with chronic renal insufficiency
when corrected for reduced glomerular filtration rate. In con-
trast, glutamine extraction by the kidneys, measured by aPe-
riovenous differences and estimates of renal blood flow, was
reduced. Total renal ammonia production (calculated from
blood arteriovenous difference + urinary excretion) was re-
duced by 50%, whereas uptake of glutamine was reduced by
90%, as compared with controls. In contrast, renal release of
serine, alanine, and leucine was increased in chronic renal
insufficiency. Total renal ammonia production was 89
zmoles/min!lOO ml GFR, and it exceeded glutamine extraction
(13 jimoles/min/l00 ml GFR). These findings indicate that
ammonia was being produced from substrates other than gluta-
mine. These authors suggested that peptide and protein catab-
olism within the diseased kidneys are the sources of most of the
renal ammonia generated in chronic renal insufficiency. If this
suggestion is true, renal ammonium excretion in this setting
would reflect local catabolism and would not reflect whole-body
metabolic acid production.
In addition to decreased urine ammonium excretion, abnor-
malities in intrarenal ammonium handling also were observed in
the renal ablation model referred to earlier [13]. As Table 2
illustrates, ammonium delivery to the end of the proximal
tubule was increased by nearly threefold when remnant kidneys
were compared with controls (66 pmol/min versus 18 pmol/
mm). This adaptive increase in response to chronic renal
Control Remnant
GFR (ml/min) 1.37 0.11 0.52 0.06
Blood pH 7.37 0.01 7.31 0.02
Urine pH 5.51 0.21 5.51 0.06
Ammonium excretionb 0.87 0.08 0.50 0.05
Net acid excretio&' 1.22 0.11 0.80 0.08
Control Remnant
End proximal delivery
Ammonium (pmol/min)
HC03 (pmol/min)
End distal delivery
Ammonium (pmol/min)
HC03 (pmol/min)
18 2
54 7
11 2
9 7
66 6
134 20
29 6
59 20
a Data from Ref. 13.
insufficiency coupled with metabolic acidosis is consistent with
the changes observed in metabolic acidosis alone (Fig. 1) [12].
In the control rats (Table 2), ammonium delivery out of the
distal tubule decreased (from 18 pmollmin to 11 pmollmin), due
to absorption in the intervening loop of Henle. Although
evidence existed for ammonia absorption in the loop in the
remnant kidney studies, the delivery of ammonium out of the
late distal tubule was higher in the remnant kidneys than in the
controls (29 pmol/min versus 11 pmol/min). These findings
should be compared with the whole-kidney measurements from
the same study, which showed an absolute decrease in renal
ammonium excretion (Table 1) [13]. If the accessible late distal
tubule samples are representative of the whole kidney, these
results suggest that ammonia absorption is stimulated in more
distal nephron segments of remnant kidneys, presumably in the
collecting system.
Although studies are just beginning to clarify the mechanisms
of nephron ammonia transport [15], the importance of ammonia
trapping in relative acidic compartments has long been recog-
nized. Along these lines, the fact that bicarbonate delivery out
of the proximal and distal tubules also was increased in the
remnant kidney model (Table 2) suggests that the final nephron
segments were presented with tubular fluid with an increased
bicarbonate content and thus were relatively alkaline. I will
address causes for increased bicarbonate delivery out of the
earlier segments shortly. These findings do suggest, however,
that the decrease in urinary ammonium excretion might be
explained simply by a limitation on the ammonia-trapping
mechanism imposed by increased bicarbonate delivery to distal
nephronal segments.
The suppressive effects of hyperkalemia on renal ammonia
production are also worth considering. Relative hyperkalemia
was commonly associated with the hyperchloremic acidosis of
early chronic renal insufficiency in the retrospective study by
Widmer et al that I alluded to earlier [71. Although all patients
with chronic renal insufficiency do not manifest hyporeninemic
hypoaldosteronism and so-called type-IV renal tubular acidosis
Early pci Late pciAbsorption
Total ammonia
transport rate,
pmol/min
Secretion
Table 1. Ammonium excretion in the remnant kidneya4
2
0
—2
—4
—6
—8
—10
—12
—14
* Data from Ref. 13.
b Units are nEq/min.
Table 2. Renal handling of ammonium and bicarbonate in the
remnant kidney*
*
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[9], this disorder of renal acid excretion [8, 16, 17] provides an
important insight into the regulation of ammonia production and
ammonium excretion. Type-IV renal tubular acidosis is com-
monly observed in patients with a variety of primary renal
diseases such as diabetes mellitus, tubulointerstitial disease,
and nephrosclerosis. In type-IV renal tubular acidosis, aldos-
terone secretion is driven by hyperkalemia rather than by the
usual renin-angiotensin axis; hyperkalemia does not appear to
fully substitute for renin deficiency, however, because these
patients do in fact have hypoaldosteronism despite hyperkale-
mia. Because hyperkalemia itself suppresses mitochondrial
ammonia production [18], a suppressive effect on renal ammo-
nia production can be manifest in patients with hyperkalemia
and chronic renal insufficiency, whether or not they have
type-IV renal tubular acidosis.
Titratable acid excretion. Urinary phosphate excretion
makes a substantial contribution to renal net acid excretion in
its capacity as a urine buffer. As I noted, the distal nephron
proton secretory systems respond normally to increases in
urine buffer delivery [11]. Given the increased serum level of
phosphate as well as the inhibitory effects of secondary hyper-
parathyroidism on renal phosphate absorption [19], it is not
surprising that phosphate excretion and urine titratable acid
formation are relatively well maintained in chronic renal insuf-
ficiency [4].
Bicarbonate reabsorption. The mechanisms underlying the
deranged renal bicarbonate handling in chronic renal insuffi-
ciency are somewhat controversial. Whole-kidney bicarbonate
reabsorption is reduced following correction of the serum
bicarbonate to normal levels. Under these circumstances,
Schwartz and colleagues found that 5 of 12 patients with
chronic renal insufficiency had marked bicarbonate excretion
and suggested that substantial bicarbonate wasting occurred
[4]. Schwartz and coworkers and Relman have suggested that
impaired renal bicarbonate absorption is common in chronic
renal insufficiency and even can occur in patients who do not
manifest overt bicarbonaturia when the serum bicarbonate level
has been corrected to normal levels [4, 5, 10]. Subsequent
studies have demonstrated an important effect of volume ex-
pansion on renal bicarbonate handling [20, 21]; this effect might
have confounded the results of Schwartz et at [4]. Some animal
studies have suggested that absolute bicarbonate absorptive
rates in fact can increase in the remaining nephrons in chronic
renal insufficiency, and that the defect in renal bicarbonate
handling might be relative to the actual filtered load at the single
nephron level (reviewed in Ref. 11). Several factors that accom-
pany chronic renal insufficiency could impair proximal bicar-
bonate reabsorption, including secondary hyperparathyroidism
[22, 23], hyperfiltration in the remaining nephrons [24], and
osmotic diuresis [25]. Whatever the mechanisms, findings in the
remnant kidney model demonstrate that bicarbonate delivery to
the end of the proximal tubule and accessible distal tubule is
augmented (Table 2) and that more bicarbonate is presented to
the collecting system than is normally the case [13]. Even
though the final urine pH (Table 1) does not directly reflect the
increase in distal bicarbonate delivery, there appears to be a
derangement in intrarenal bicarbonate handling in chronic renal
insufficiency.
Table 3. Adaptation of Na/H antiporter to metabolic acidosisa
Blood pH 7.42 0.06 7.11 0.04
Ymax (fluorescence units/sec. mg protein)
Outer cortex 3.6 0.02 5.0 0.02
Inner medulla 0.8 0.03 0.9 0.04
a Data taken from Ref. 35.
Cellular mechanisms of acidification
Transport processes. The reabsorption of water and solute by
the proximal tubule is a dynamic process that can adapt to
changes in several physiologic factors: glomerular filtration
rate, hormones, and acid-base and electrolyte balance. The
major mechanism for proton secretion and bicarbonate reab-
sorption in the proximal tubule is the Na/H antiporter of the
brush-border membrane [26]. Adaptive increases in the maxi-
mal transport rate (Vmax) of the Na/H antiporter have been
demonstrated in metabolic acidosis [27—29] and decreases have
been shown in the maximal transport rate in alkalosis [30].
Other factors, including parathyroidectomy, glucocorticoid ad-
ministration, unilateral nephrectomy, potassium depletion, and
renal ablation, also increase the Vmax of the brush-border
Na/H antiporter [27, 3 1—34]. Most of the Na/H antiporter
has been localized to the first two-thirds of the proximal tubule.
This segment also is the site of the adaptive increase in activity
observed in metabolic acidosis [35]. As Table 3 illustrates,
metabolic acidosis increased the max of the Na/H antiporter
by 40% in brush-border vesicles prepared from the outer cortex
of rabbit kidneys, presumably representing earlier segments of
the proximal tubule. In contrast, the basal rate of Na/H
exchange was much lower in the inner cortical brush-border
vesicles, and no adaptive increase occurred in response to
metabolic acidosis (Table 3).
We and others have described an electrogenic sodium/bicar-
bonate cotransporter in basolateral membrane vesicles pre-
pared from rabbit renal cortex [36, 37]. This transporter plays
an important role in bicarbonate reabsorption and in regulation
of intracellular pH in the proximal tubular cell [38—46]. Al-
though the factors regulating the activity of this transporter
have not yet been identified, it is believed that the sodium!
bicarbonate cotransporter is the primary pathway by which
base equivalents are transported across the basolateral mem-
brane.
Recent work has established that systemic pH, and therefore
peritubular pH, play an important role in the regulation of
bicarbonate reabsorption in the proximal tubule [26, 47]. In-
deed, the proximal tubule's intrinsic reabsorptive capacity for
bicarbonate is increased in chronic respiratory [48] and meta-
bolic acidosis [49], and is decreased in chronic metabolic
alkalosis [50]. Bicarbonate reabsorption represents a vectorial
process by which H is secreted across the brush-border
membrane, and base equivalents are transported across the
basolateral membrane; this scheme raises the possibility that
the activity of the bicarbonate reabsorptive processes in both
membranes could be adaptively regulated during states of
chronic acid-base disturbance. In fact, we have shown that the
activity of the Na/H antiporter and the sodium/bicarbonate
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Fig. 2. In-vivo infusion of parathyroid hormone in
the rat. These results were obtained during the
indicated time periods while parathyroid hormone
was infused in rats; * = P < 0.01. Shown are the
rates of glomerular filtration (mi/mm), urinary
bicarbonate and phosphate excretion (nmoi/min), and
urine pH. (Reproduced by permission of the
American Journal of Physiology [60].)
cotransporter are coordinately regulated during chronic meta-
bolic acidosis and alkalosis [51]. This finding has an important
implication for the defense of intracellular pH during chronic
acid-base derangements. If only the apical Na/H exchanger
were activated in metabolic acidosis, cell pH would increase as
more protons were removed from the cell. On the other hand, if
both transporters are activated during acidosis, the overall net
rate of transcellular proton secretion would be increased be-
cause H extrusion across the apical membrane and HC03
exit across the basolateral membrane both would be increased.
This adaptation would maintain intracellular pH at a lower level
than that which could result if only the apical Na/H transport
system were increased [51]. Furthermore, such an adaptive
process probably would be more sensitive to regulation by
intracellular pH than to changes in systemic extracellular pH.
Parathyroid hormone. I now would like to turn to the effects
of parathyroid hormone on renal acidification processes at the
cellular level. Parathyroid hormone acutely inhibits phosphate
and bicarbonate reabsorption in the proximal tubule. Our group
has studied these effects in an established renal cell line from
the opossum kidney. A distinguishing feature of this cell line is
its response to parathyroid hormone at the adenylate cyclase
level [52] and at the membrane transport level [53]. The
opossum kidney cells have many characteristics of cultured
proximal tubular cells, including NC/HP exchange [54, 55],
sodiumlphosphate cotransport [56], and acute regulation of
both transport systems by cyclic AMP (Table 4) [54-56]. The
effects on NC/HP antiporter activity could be detected at 10
picomolar parathyroid hormone concentration and were limited
to the amiloride-sensitive component of 22Na exchange [54].
Kinetic analysis indicates that parathyroid hormone acutely
decreases the maximal rate of transport and shifts the internal
pH sensitivity of the Na/H exchanger in the acidic (that is,
less sensitive) direction [55]. In addition, sodium-dependent
phosphate transport is reduced by parathyroid hormone (Table
4). These subcellular effects, obtained with short-term exposure
of the cultured cells to parathyroid hormone, are entirely
consistent with the overall renal effects of parathyroid hor-
mone, and can well explain the bicarbonaturic and phosphaturic
responses to parathyroid hormone.
In contrast to these acute effects, administration of parathy-
roid hormone or active metabolites of vitamin D for one to 2
weeks has been found to increase renal net acid excretion and
Table 4. Effect of PTH on opossum kidney cells
Na/W Antiporterb
ControF
76.0 16.0
+PTW
58.0 13.0
Na7PO4 Cotransportere 2.1 0.1 1.2 0.1
a Maximal transport rates are given in nmoles/min/mg protein.
b Data from Ref. 55.
Data from Ref. 56.
to cause metabolic alkalosis rather than acidosis [57]. This
discrepancy might partially result from the combined renal and
extrarenal effects of parathyroid hormone. The buffering capac-
ity of the skeletal system [58] and the effects of parathyroid
hormone and vitamin D metabolites on the bone [57] cannot be
ignored in considering chronic acid-base homeostasis in chronic
renal insufficiency. The importance of this defense of acid-base
homeostasis is emphasized by the immense carbonate content
of the skeleton [2]; skeletal buffering of H may well explain the
stability of uremic acidosis, that is, the common observation
that serum bicarbonate levels can remain relatively constant
despite ongoing H retention. Calcium loss from bone (negative
calcium balance) has been observed during metabolic acidosis
[58]; such calcium depletion might play a role in the osteodys-
trophy that develops during the course of chronic renal insuf-
ficiency [59].
The divergent responses to parathyroid hormone are illus-
trated in the in-vivo infusion study presented in Figure 2 [60].
The glomerular filtration rate and urine bicarbonate excretion
rate rapidly increased in response to parathyroid hormone,
returning to baseline levels during the last half of the 2-hour
infusion period. In contrast, the increase in urine phosphate
excretion was sustained throughout the entire infusion period.
Of note are the changes in urine pH, which increased during the
periods that corresponded to the increase in bicarbonate excre-
tion; however, urine pH fell substantially thereafter. These
effects are explained in part by the increase in phosphate
delivery to distal nephron sites, which provokes proton secre-
tion in response to this increase in buffer (phosphate) delivery.
In addition, the fall in urine pH (Fig. 2) also raises the
possibility that parathyroid hormone might stimulate proton
secretion in more distal parts of the nephron. An increase in
fractional bicarbonate reabsorption was observed during para-
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thyroid hormone infusion in the ioop of Henle [60], a site where
a sodium-dependent, amioride-sensitive bicarbonate absorp-
tive process was recently identified in the rat [61].
Cyclic AMP-mediated acid jfication. Proton AlPases make a
relatively minor contribution to proximal tubule acidification,
but they appear to play a major role at more distal sites via
endocytotic and exocytotic vesicles [26]. It is interesting to
consider the possibility that these systems might be regulated
by cyclic AMP (cAMP). Regulation of luminal H secretion in
the turtle urinary bladder has been attributed to fusion of
intracellular vesicles with the apical membrane [62]. Previous
studies with the turtle urinary bladder showed that 10 mM
cAMP decreased transepithelial H secretion [63]; these results
are similar to those observed with parathyroid hormone and
cAMP in studies of the proximal tubule apical membrane
Na/H antiporter [54, 55]. Paradoxically, stimulatory effects
of 1 mM dibutyryl cAMP on H transport also have been
observed in the urinary bladder of the Colombian toad [64].
Recent studies in the isolated, perfused rabbit medullary col-
lecting duct [65] have demonstrated a stimulatory effect of 0.01
mM dibutyryl cAMP on H secretion. The effect of cAMP on
the intact tissue may be complex and could include effects on
the basolateral base exit step and insertion of H ATPase into
the apical membrane. Preliminary results from our group sug-
gest that inhibition, stimulation, or both of H secretion in a
specific subset of endocytotic vesicles from rabbit renal cortex
also might contribute to the regulatory effects of cAMP on
transepithelial H transport [66]. Therefore, the overall effect
of parathyroid hormone on renal acidification is complex.
Bicarbonate and phosphate absorption are clearly acutely in-
hibited in the proximal tubule by parathyroid hormone, and the
increased buffer delivery would alkalinize the tubular fluid
delivered to more distal sites. In addition, parathyroid hor-
mone, or even cyclic AMP generated at its proximal site of
action, could regulate H transport systems in the distal
nephron.
In summary, metabolic acidosis develops during the course
of chronic renal insufficiency because of an inadequate adapta-
tion of net renal acid excretion to the requirements for acid-base
homeostasis. Although the primary defect appears to be in
overall renal ammonium excretion, it is not certain that renal
ammonia production per se is rate-limiting. Recent studies have
suggested that intrarenal bicarbonate handling may be de-
ranged, with increased delivery of bicarbonate out of the
proximal tubule due to the combined effects of parathyroid
hormone, volume expansion, and increased glomerular filtra-
tion in the remaining nephrons. As a consequence of the
increase in bicarbonate delivery, relatively alkaline tubule fluid
is delivered to distal nephron sites, thus decreasing the effi-
ciency of ammonia trapping and thereby decreasing urinary
ammonium excretion. It also appears that chronic parathyroid
hormone excess might stimulate distal nephron proton secre-
tion and increase titration of urinary buffers; urine titratable
acid formation is thereby well maintained as chronic renal
insufficiency develops even though urine ammonium excretion,
and therefore net acid excretion, are reduced. Bone buffer
stores defend acid-base homeostasis, and the long-term effects
of such buffering may contribute to the development of renal
osteodystrophy. In any particular patient (as in the one pre-
sented today), the severity of the metabolic acidosis might not
be striking as renal insufficiency develops, but the underlying
pathophysiologic mechanisms will take their toll.
Questions and answers
Da. JEROME P. KASSIRER (Associate Physician-in-Chief,
New England Medical Center, Boston, Massachusetts): In the
late 1950s, Schwartz and Relman showed that a minority of
patients with chronic renal failure did, in fact, have bicarbonate
wasting. Could you comment on these data in light of what we
know today?
DR. WARNOCK: Persisting excretion of bicarbonate in this
setting could simply reflect mild volume expansion such that the
filtered load of bicarbonate exceeds the overall renal bicarbon-
ate absorptive capacity. In terms of the thesis that I have
developed today, it seems likely that a derangement exists in
intrarenal bicarbonate handling in chronic renal insufficiency.
The data summarized in Table 2 demonstrate that bicarbonate
delivery to more distal sites is increased, at least in the remnant
kidney model. If the distal proton secretory systems do not
respond to this increase in buffer delivery, due for instance to
selective aldosterone deficiency, bicarbonaturia will result. It is
fortunate that this is observed only in a minority of patients with
chronic renal insufficiency [3] because a persistent loss of
bicarbonate in the urine would clearly increase the severity of
uremic acidosis.
DR. KASSIRER: In essence, it seems that in chronic renal
failure the proximal tubule is at fault in not reabsorbing bicar-
bonate, and the distal tubule is unable to catch up.
DR. WARNOCK: Exactly. Most patients, however, do elabo-
rate an acid urine and do respond normally to increases in
urinary buffers. These observations indicate that usually the
function of distal proton secretion systems is well maintained.
DR. JOHN T. HARRINOTON (Chief of Medicine, Newton-
Wellesley Hospital, Newton, Massachusetts): Dr. Warnock, I
am not sure about some of the quantitative aspects of the data
you presented. I believe that you stated that ammonia produc-
tion could increase twofold in the proximal tubule in metabolic
acidosis, yet there was a four- to fivefold increase in urinary
ammonia excretion in the same studies. Doesn't this suggest
that distal tubule ammonia production increases substantially in
chronic renal failure?
DR. WARNOCK: Not really. The capacity of the proximal
tubule cell to produce ammonia is really quite large, but much
of it is usually returned to the systemic circulation rather than
being excreted in the urine [14]. Your calculations are correct in
a fractional sense, but when one considers the absolute rate of
proximal ammonia production compared with the absolute rate
of urinary ammonium excretion, it is clear that a twofold
increase in production rate is more than sufficient to account for
a fivefold increase in urinary excretion rate.
DR. KASSIRER: How relevant is the pathogenesis of metabolic
acidosis as seen in the remnant kidney to that seen in human
chronic renal failure?
DR. WARNOCK: I am surprised that the remnant model needs
defending in Boston, but I share your reservations. Whereas
this model might not be a perfect analogue of chronic renal
insufficiency, its virtues certainly have not gone unheralded. To
imply that this model is not "relevant" to human chronic renal
failure is probably a bit strong.
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Da. NIcoLAos E. MAmAS (Chief Division of Nephrology,
New England Medical Center): Although in general the severity
of uremic acidosis worsens as a function of the degree of renal
failure, several studies have identified patients whose plasma
bicarbonate concentration has been in the lower limits of the
normal range despite even severe degrees of renal failure. In
such patients, vomiting or exposure to substances that could
elevate plasma bicarbonate concentration—such as diuretics,
alkali, and steroids—have been excluded. Do you ascribe this
phenomenon to relatively better preservation of renal acidifica-
tion in these patients, or might it be that they have increased
participation of extrarenal buffering?
DR. WARNOCK: My presentation has focused on the renal
proton and bicarbonate transport mechanisms at a tubular and
cellular level. As your question implies, however, it would be a
mistake to lose sight of the important role played by the skeletal
buffer stores in the long-term response to metabolic acidosis.
The buffer power of bone, especially its carbonate content, is
immense [2]. It seems quite plausible that skeletal buffering of
H could well explain the commonly observed stability of
uremic acidosis, that is, the fact that the serum bicarbonate
level can remain relatively constant despite ongoing retention of
hydrogen ion. In fact, a dramatic finding in the case presented
today is the relatively mild acidosis despite well-documented
hyperparathyroidism and severe renal insufficiency.
DR. KASSIRER: In fact, in the patient we are discussing today,
I could argue that the administration of furosemidc, by increas-
ing distal hydrogen ion secretion, and calcium carbonate, by
increasing alkali stores, was responsible for the lack of severe
acidosis.
DR. WARNOcK: I certainly agree that these factors could have
contributed to the maintenance of relatively normal acid-base
balance in this patient. It has never been clear to me, however,
how furosemide increases distal hydrogen ion secretion. It
might be worth speculating that inhibition of an anion exchange
process, such as the chloride/bicarbonate exchanger present in
parallel with a Na/H exchanger in the thick ascending limb of
some species [61], would augment Htm secretion by limiting
base entry into the luminal fluid.
DR. KASSIRER: As a followup to my question, is there any
correlation between severity of uremic acidosis and degree of
osteodystrophy?
DR. WARNOCK: That is a difficult question to answer because
of the heterogeneity of bone lesions that we usually lump under
the term "renal osteodystrophy." It is clear that negative
calcium balance can be demonstrated in acidosis and that the
resulting calcium depletion may well play an important role in
the development and progression of the renal osteodystrophies
[59].
DR. RONALD D. PERRONE (Division of Nephrology, New
England Medical Center): You alluded to the possible protec-
tive effect of increased PTH levels in chronic renal failure by
"keeping acid out." Yet intracellular pH faIls. How do you
reconcile this discrepancy?
Da. WARNOCK: I didn't mean to imply that PTH plays any
"protective role" in chronic renal insufficiency. As you know,
some have even concluded that VFH is one of the uremic
toxins. If PTH chronically inhibits the Na/H antiporter in the
proximal tubule, the cell pH will be set at a lower level [54, 55],
which I agree would probably be deleterious in the long run.
Alternatively, if distal proton secretory ystems are in fact
stimulated by PTH or by cAMP produced in the proximal
tubule and delivered distally, the cell pH (in those cells)
obviously would rise.
Da. MADIAS: You stated that the ability to acidify the urine
remains intact in chronic renal failure. Although uremic patients
who are free of bicarbonate wasting do indeed excrete an acidic
urine, their urine pH usually falls short (by at least 0.5 pH units)
of the level attained by normal subjects following experimen-
tally induced metabolic acidosis. This point is borne out by the
data presented in Table 1 in which rats with uremic acidosis had
a urine pH no lower than that of control, non-acidotic rats.
Doesn't this suggest the presence of a subnormal ability to
acidify the urine in chronic renal failure?
DR. WARNOCK: We should always allow for that possibility.
However, the thesis that I have developed today focuses on the
actual increase in delivery of a volatile buffer (bicarbonate) to
distal sites in chronic renal insufficiency. Therefore, increased
proton secretion in the distal tubules could accommodate this
increased buffer load without there being acorresponding fall in
the urinary pH.
DR. MAmAs: I found your analysis of the effects of PTH on
acidification processes particularly intriguing. These divergent
effects on the proximal and distal nephron might account for the
fact that patients with primary hyperparathyroidism usually do
not feature substantial abnormalities in their acid-base status.
On the other hand, I am aware of few published reports on
uremic patients with substantial bicarbonaturia and marked
secondary hyperparathyroidism whose bicarbonate wasting
was ameliorated following parathyroidectomy. Do you know of
any systematic data describing the effects of parathyroidectomy
on the acid-base status of uremic patients?
DR. WARNOCK: I am not aware that this issue has been
carefully studied. If PTH decreases proximal bicarbonate reab-
sorption but can also stimulate distal H secretion, the effect of
parathyroidectomy might not be manifest in the urine even
though substantial changes in thó intrarenal handling of bicar-
bonate might have occurred.
DR. HARRINOTON: As you know, we have been intetested in
the stimuli to renal acid excretion for many years [67, 68]. One
striking study strongly suggesting that systemic acidosis is not
critical to the stimulation of renal acid excretion was reported
by Lowance and colleagues in the early l970s [69]. These
investigators demonstrated that the administration of antidi-
uretic hormone and water to animals in the steady-state phase
of chronic metabolic acidosis resulted in an increase in renal
acid excretion and a return of plasma biáarbonate to normal.
Later studies performed here by the same group in collabora-
tion with Dr. James Mélby at Boston University demonstrated
the critical role of aldosterone in producing this response [70].
My question to you is, how do you explain the increase in renal
acid excretion in the Lowance studies, while systemic acidemia
is waning?
DR. WARNOcK: It is possible that the central issue is in fact
cell pH rather than systemic pH. Many of the factors that cause
adaptive changes in the renal acidification mechanisms (for
example, acidosis, alkalosis, and glucocorticoids) can be dem-
onstrated when the tubule or membrane is removed from the
kidney and studied in a defined in-vitro setting. These adaptive
changes usually take relatively long to be established (days),
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and are manifest by the in-vitro "memory effect" that I have
just described. Therefore I don't think it is surprising that these
transport systems can be acutely dissociated from changes in
acid-base status because it can take hours or even days for the
membrane transport proteins to be "retooled." The recent
demonstration of increased brush border vesicle Na/H ex-
change in post-hypercapnic metabolic alkalosis is an excellent
example of these phenomena [71].
DR. MADIAs: Recent observations by Wallia and colleagues
have suggested that, in contrast to the common belief that
high-anion-gap metabolic acidosis typifies advanced uremic
acidosis, normal-anion-gap acidosis or a hybrid type of acidosis
(that is, mixed high- and normal-anion-gap acidosis) is common
among patients with severe renal failure [72]. How do you
account for these findings, and to what extent do you think this
observation is due to a component of hypoaldosteronism or
aldosterone resistance?
DR. WARNOCK: I wouldn't want to defend the position that
the distal proton secretory systems are perfectly intact in
chronic renal insufficiency. Clearly, the ability to generate a pH
gradient, especially if buffer delivery is low, is nearly normal.
The maximal capacity to secrete protons is much more difficult
to assess. If there is increased bicarbonate delivery to the distal
tubule in this setting, then it is difficult to know what the actual
buffer load is that is delivered distally. I think the idea of
aldosterone resistance, separate from selective aldosterone
deficiency, is well worth considering and merits direct experi-
mental examination.
DR. KASSIRER: I never have been fond of the designation
"anion-gap acidosis," principally because this term implies a
causal relation between the anion and the acidosis. In organic
acidoses such as ketoacidosis and lactic acidosis, acidosis is
caused by the accumulation of hydrogen ions, and the anion is
merely an accompaniment of hydrogen ion. In fact, in such
types of acidosis, the anion, when metabolized, is the source of
alkali to replenish lost bicarbonate stores. In renal acidosis,
acidosis is caused by failure of hydrogen ion excretion, and the
increase in plasma anions is merely the consequence of a
retention of anions consequent to a low glomerular filtration
rate. Because failure of hydrogen ion excretion and failure of
anion excretion are unlinked processes in chronic renal failure,
numerous examples exist in which discrepancies occur between
the degree of acidosis and the degree of anion retention. Maybe
I'm being a purist, but I believe that the way we describe
medical concepts is important. Lavoisier also worried about
this issue nearly 200years ago. In Traite Elementaire de Chimie
(1789) he wrote, "It is impossible to dissociate language from
science or science from language, because every natural sci-
ence always involves three things: the sequence of phenomena
on which the science is based; the abstract concepts which call
these phenomena to mind; and the words in which the concepts
are expressed. To call forth a concept a word is needed; to
portray a phenomenon a concept is needed. All three mirror one
and the same reality." Do you have similar concerns?
Da. WARNOCK: I would never dispute Lavoisier, and would
disagree with Kassirer only on rare occasions. In fact, I am
somewhat fond of the term "anion-gap acidosis" precisely
because of Lavoisier's dictum. I find this phrase of great utility
in explaining the concepts of metabolic acidosis to medical
students. Furthermore, I would even be willing to defend the
causality that you find questionable. In fact, the metabolism of
sulfur- and phosphorus-containing organic substances can be
viewed as producing H7S04 and H3P04. These are very strong
acids that could never be excreted as such in the urine because
of the difference between their pKs and the lowest possible
urinary pH. Therefore, these anions can only be excreted as
sodium salts, whereas the attendant protons are excreted as
ammonium ions. In this sense, then, the fact that these anions
accumulate indicates of course that the filtered load and urinary
excretion are not sufficient to clear them from the circulation. In
addition, we should not lose sight of the fact that these anions
do represent a challenge to the maintenance of normal acid-base
status in that bicarbonate was consumed during the course of
hydrogen ion liberation from their conjugate acids.
DR. MADIAS: What are your recommendations on the treat-
ment of uremic acidosis?
DR. WARNOCK: How should we treat uremic acidosis? Clear-
ly, bicarbonate supplementation can be beneficial, especially if
it can be given as calcium carbonate along with vitamin D so
that the underlying defects in gut calcium absorption are also
addressed. Evaluation of the renin-aldosterone axis and supple-
mental mineralocorticoids are needed, if indicated. As I previ-
ously mentioned, furosemide treatment with added salt if
needed also might be useful. Finally, aggressive management of
hyperkalemia with dietary modification and exchange resins are
helpful.
As you realize, these approaches are the mainstays of the
traditional, conservative approach to managing chronic renal
failure. Nothing in my presentation would change our current
management of uremic acidosis, but I hope that our thinking has
been more clearly focused on the underlying pathophysiology.
Reprint requests to Dr. D. Warnock, Nephrology Section (JJJJ,), San
Francisco Veterans Administration Medical Center, 4150 Clement
Street, San Francisco, California 94121, USA.
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